Table 1.
Prevalence studies of progressive supranuclear palsy
| Published studies | Study region (point/period) | Number of cases (male:female) | Crude prevalence (per 105) |
|---|---|---|---|
| Golbe et al., 1988 [58] | New Jersey, USA (5/1/1986) | 11 (6:5) | 1.4 |
| De Rijk et al., 1995 [64] | Rotterdam, Netherlands (1990- 1993) | 1 (N/A) | 14.3 (>55 years old) |
| Wermuth et al., 1997 [61] | Faroe Islands (7/1/1995) | 2 (N/A) | 4.6 |
| Chiò et al., 1998 [62] | Socio-Sanitary District, Italy (10/20/1991) | 2 (N/A) | 3.2 |
| Schrag et al., 1999 [59] | London and Kent, UK (7/1/1997) | 6 (3:3) | 4.9 |
| Nath et al., 2001 [60] | National study, UK (1/1/1999) | 187 (91:96) | 0.3 |
| Nath et al., 2001 [60] | Northern England, UK (1/1/1999) | 80 (31:49) | 3.1 |
| Nath et al., 2001 [60] | Newcastle upon Tyne, UK (1/1/1999) | 17 (8:9) | 6.5 |
| Kawashima et al., 2004 [65] | Yonago, Japan (4/1/1999) | 8 (6:2) | 5.8 |
| Wermuth et al., 2008 [63] | Faroe Islands (7/1/2005) | 2 (N/A) | 4.1 |
| Osaki et al., 2011 [66] | Kochi, Japan (11/1/2007) | 12 (8:4) | 18 |
| Takigawa et al., 2016 [67] | Yonago, Japan (10/1/2010) | 25 (12:13) | 17.9 |
| Fleury et al., 2018 [68] | Canton, Switzerland (1/1/2013) | 39 (22:17) | 8.3 |
N/A: Not available